Assessing the predictive validity of frog embryo teratogenesis assay - Xenopus (FETAX)

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 20, Issue 2, 2000, Pages 87-98

  Fort, Douglas J ^a   Stover, Enos L ^a   Farmer, Donna R ^b   Lemen, Joan K ^b  

^a Stover Group   (United States)

^b MONSANTO COMPANY   (United States)

Author keywords

Chemical prioritization; FETAX; Hazard assessment; Integrated biological assessment; Teratogen

Indexed keywords

ANTINEMATODAL AGENT; FUNGICIDE; HERBICIDE; TERATOGENIC AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; EMBRYO; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; TERATOGENESIS; VALIDATION PROCESS; XENOPUS LAEVIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; EMBRYO, NONMAMMALIAN; EMBRYONIC AND FETAL DEVELOPMENT; EVALUATION STUDIES; FEMALE; MALE; MATERNAL-FETAL EXCHANGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TERATOGENS; TOXICITY TESTS; XENOPUS LAEVIS;

ANIMALIA; ANURA; XENOPUS LAEVIS;

EID: 0033964610     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(2000)20:2<87::AID-TCM4>3.0.CO;2-6     Document Type: Article

References (22)

1. Dumont JN, Schultz TW, Buchanan M, Kai G. Frog embryo teratogencsis assay: Xenopus. A short-term assay application to complex environmental mixtures. In: Waters MD, Sandhu SS, Lewtas J, Claxton L, Chernoff N, Nesnow S, editors. Symposium on the application of short-term bioassays in the analysis of complex environmental mixtures III. New York: Plenum Press; 1983. p 393-405.
2. Fort DJ, Dawson DA, Bantle JA. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX). Teratogen Carcinogen Mutagen 1988;8:251-263.
3. Fort DJ, Dawson DA, Bantle JA. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system. J Appl Toxicol 1989;9:366-377.
4. Fort DJ, Rayburn JR, DeYoung DJ, Bantle JA. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX. Drug Chem Toxicol 1991;14:143-160.
5. Dawson DA, Fort DJ, Smith GJ, Newell DL, Bantle JA. Evaluation of developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus. Teratogen Carcinogen Mutagen 1988;8:329-388.
6. Fort DJ, Bantle JA. Use of frog embryo teratogenesis assay: Xenopus (FETAX) to evaluate the developmental toxicity of diphenylhydantoin. Fundam Appl Toxicol 1990;14:720-733.
7. Fort DJ, Bantle JA. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX). Teratogen Carcinogen Mutagen 1990;10:463-476.
8. Fort DJ, Rayburn JR, Bantle JA. Evaluation of acetaminophen-induced developmental toxicity using FETAX. Drug Chem Toxicol 1992;15:329-350.
9. Fort DJ, Stover EL, Rayburn JR, Hull M, Bantle JA. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus. Teratogen Carcinogen Mutagen 1993;13:35-45.
10. Fort DJ, Stover EL, Rayburn JR, Hull M, Bantle JA. Evaluation of the developmental toxicity of theophyline, dimethyluric acid, and methylxanthine metabolites using FETAX. Drug Chem Toxicol 1996;19:267-278.
11. Fort DJ, Stover EL, Propst T, Hull MA, Bantle JA. Evaluation of the developmental toxicities coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX. Drug Chem Toxicol.
12. Lucier G, McDaniel O, Brubaker P, Klien R. Effects of methylmercury chloride on rat liver microsomal enzymes. Chem Biol Interact 1971;4:265-280.
13. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemistry 1955;55:412-416.
14. Bradford MM. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
15. ASTM. Standard guide for conducting the frog embryo teratogenesis assay - Xenopus (FETAX). E1439-91. Philadelphia: American Society for Testing and Materials; 1991.
16. Dawson DA, Bantle JA. Development of a reconstituted water media and preliminary validation of the frog embryo teratogenesis assay: Xenopus (FETAX). J Appl Toxicol 1987;7:237-244.
17. Nieuwkoop DD, Faber J. Normal tables of Xenopus laevis (Daudin). Amsterdam: North-Holland; 1975.
18. Schultz TW, Ranney TS, Riggin GW, Cajina-Quezada M. Structure-activity relationships for osteolathyrism. I. Effects of altering the semicarbazide structure. Trans Am Microsc Soc 1988; 107:113-126.
19. Schultz TW, Ranney TS. Structure-activity relationships for osteolathyrism. II. Effects of four-position alkyl substitution of formic acid hydrazide. Toxicology 1988;53:147-159.
20. Dawson DA, Schultz TW, Baker LL, Mannar A. Structure activity relationships for osteolathyrism. III. Substituted thiosemicarbazides. J Appl Toxicol 1990;10:59-64.
21. Dawson DA. Chemical mixture toxicity assessment using an alternative-species model: applications, opportunities, and perspectives. In: Yang RSH, editor. Toxicology of chemical mixtures: case studies, mechanisms and novel approaches. San Diego: Academic Press; 1994. p 539-563.
22. Dawson DA, Schultz TW, Hunter RS. Developmental toxicity of carboxylic acids to Xenopus embryos: a quantitative structure-activity relationship and computer-automated structure evaluation. Teratogen Carcinogen Mutagen 1996;16:109-124.